Top Buy
Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 75 | 0 | 13 | 0 | 815,00 € | 831,01 € | 1,96 % |
BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | 64,06 € | 100,74 € | 57,26 % |
Evotec SE | 10 | 1 | 8 | 0 | 6,44 € | 48,50 € | 653,11 % |
Cigna Corp. | 28 | 0 | 6 | 0 | 320,50 € | 360,98 € | 12,63 % |
Pfizer Inc. | 31 | 4 | 6 | 0 | 26,79 € | 40,73 € | 52,08 % |
Bayer AG | 18 | 10 | 6 | 9 | 27,91 € | 45,00 € | 61,26 % |
Centene Corp. | 28 | 0 | 5 | 0 | 68,73 € | 82,38 € | 19,86 % |
UnitedHealth Group Inc. | 45 | 1 | 5 | 0 | 522,70 € | 546,99 € | 4,65 % |
Neurocrine Bioscience | 42 | 0 | 5 | 0 | 107,90 € | 155,89 € | 44,48 % |
PTC Therapeutics Inc. | 18 | 8 | 5 | 0 | 30,80 € | 41,51 € | 34,78 % |
Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | 68,00 € | 85,00 € | 25,00 % |
Novo Nordisk A/S ADR | 26 | 1 | 5 | 0 | 119,00 € | 144,83 € | 21,71 % |
Cytokinetics Inc. | 35 | 1 | 5 | 0 | 50,50 € | 83,13 € | 64,62 % |
Alnylam Pharmace. | 45 | 0 | 4 | 0 | 246,10 € | 276,49 € | 12,35 % |
Immunic Inc. | 8 | 3 | 4 | 0 | 1,62 € | 6,43 € | 297,84 % |
Evolus Inc | 15 | 0 | 4 | 0 | 14,90 € | 20,43 € | 37,13 % |
Stryker Corp. | 33 | 0 | 4 | 0 | 325,40 € | 342,93 € | 5,39 % |
Boston Scientific | 56 | 0 | 4 | 0 | 74,50 € | 78,23 € | 5,01 % |
Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | 1.025,5 € | 1.089,7 € | 6,26 % |
Johnson & Johnson | 41 | 1 | 4 | 0 | 149,62 € | 194,53 € | 30,02 % |
MannKind Corp. | 12 | 0 | 4 | 0 | 5,88 € | 6,92 € | 17,73 % |
Exact Sciences | 20 | 0 | 3 | 0 | 62,34 € | 76,55 € | 22,79 % |
Merit Medical Systems | 24 | 0 | 3 | 0 | 88,50 € | 90,71 € | 2,49 % |
Illumina Inc. | 33 | 4 | 3 | 0 | 117,92 € | 158,42 € | 34,35 % |
Sanofi S.A. ADR | 8 | 0 | 3 | 0 | 52,00 € | 55,25 € | 6,26 % |